We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Authorities Seize GSK's Paxil CR, Avandamet Over cGMP Violations
U.S. Authorities Seize GSK's Paxil CR, Avandamet Over cGMP Violations
March 4, 2005
The FDA and the Justice Department have halted the distribution of GlaxoSmithKline’s (GSK) antidepressant Paxil CR and diabetes drug Avandamet because of ongoing concerns about the manufacturing quality of the products.